Digoxin and Nimbex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Nimbex (cisatracurium besylate). Common drug interactions include arrhythmia among females and injury among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Nimbex. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.



On Jul, 10, 2026

24 people who take Digoxin and Nimbex together, and have interactions are studied.

Digoxin and Nimbex drug interactions.

What are the common drug interactions of Digoxin and Nimbex, by gender? *:

female:

  1. Arrhythmia (irregular heartbeat)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiac disorder
  6. Cardiac failure congestive
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Cardiac valve disease (heart valve disease)
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Cardiomyopathy (weakening of the heart muscle)

male:

  1. Injury
  2. Pain
  3. Abdominal pain
  4. Dyspnoea (difficult or laboured respiration)
  5. Endocarditis (inflammation in heart muscle)
  6. Hyperpyrexia (extremely high fever)
  7. Pyrexia (fever)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Staphylococcal bacteraemia (a bacterial infection of blood)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Digoxin and Nimbex, by age (0-1 to 60+)? *:

0-1:

  1. Injury
  2. Abdominal distension
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Activities of daily living impaired
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anuria (failure of the kidneys to produce urine)
  7. Anxiety
  8. Aortic valve incompetence
  9. Apnoea (suspension of external breathing)
  10. Arrhythmia (irregular heartbeat)

2-9:

  1. Mental disability
  2. Multi-organ failure (multisystem organ failure)
  3. Pain
  4. Physical disability
  5. Renal failure (kidney dysfunction)
  6. Stress
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Blindness
  10. Brain injury

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiac arrest
  2. Cardiomegaly (increased size of heart than normal)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Pulmonary veno-occlusive disease (obstructive disease of the pulmonary veins)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Cardiac arrest
  2. Pain
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
  4. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  5. Anxiety
  6. Fear
  7. Renal impairment (severely reduced kidney function)
  8. Stress
  9. Bradycardia (abnormally slow heart action)
  10. Emotional distress

What are the existing conditions these people have? *

  1. Muscle Function Loss: 7 people, 29.17%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Nimbex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nimbex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and cisatracurium besylate (the active ingredients of Digoxin and Nimbex, respectively), and Digoxin and Nimbex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: